Search Results 381-390 of 11777 for ���������������������������:za33���24������ ������������������������ ������

  1. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Participation eligibility · Calculated creatinine clearance ≥30 mL/min using a modified Cockcroft-Gault calculation or a 24-hour urine collection for Creatinine ...

  2. Florida - 2012 Archives - Mayo Clinic News Network

    September 24, 2012. Fund to Honor a Mother Aims to Transform Brain Cancer Care. Kevin Punsky. September 20, 2012. Mayo Clinic Researchers Identify New Enzyme To ...

  3. Cardiovascular - 2014 Archives - Mayo Clinic News Network

    December 24, 2014. Some medical discoveries truly stand the test of time. The case of a dedicated Mayo Clinic chemist is a prime example. Feeling he was on ...

  4. Deb Balzer | Mayo Clinic News Network - Page 60 of 73

    Penicillin, discovered in 1928 by Sir Alexander Fleming, is recognized as one of the greatest advances in[...] By Deb Balzer • April 24, 2017. Infectious ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  6. Barriers to Achieving Diabetes Excellence in an American Indian Community in Minnesota - Mayo Clinic

    Rochester, Minnesota: 24-001808. About this study. The purpose of this study is to conduct a survey and focus group of individuals with diabetes and key ...

  7. Medical Research & Education - Mayo Clinic News Network

    December 24, 2021. Global study finds metabolic syndrome increased risk of acute respiratory distress syndrome, death in patients. Individualized Medicine.

  8. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  9. A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide - Mayo Clinic

    ... 24 hours; or (iii) light chain multiple myeloma without measurable M-protein in the serum or the urine: serum immunoglobulin (Ig) free light chain (FLC) ...

  10. A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression - Mayo Clinic

    Rochester, Minnesota: 24-000337; Jacksonville, Florida: 24-000337. NCT ID: NCT06051695. Sponsor Protocol Number: A2B694-101. About this study. The goal of this ...